Accreditation Statement and Credit Designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
How to Receive Credit
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA Category 1 Credit(s)™. You must complete the post-test and evaluation in order to receive credit for this activity.
All other participants who successfully complete the post-test and evaluation will receive a certificate of completion.
A statement of credit will be e-mailed to you and will also be available to print from your user history page.
Disclosure of Conflicts of Interest
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Dr. Sandborn has received consulting fees from Janssen, Abbott Laboratories (now AbbVie), UCB Pharma, Salix, Shire, Warner Chilcott, Prometheus Laboratories, Santarus, Bristol-Myers Squibb, Genentech, Amgen, Pfizer, Receptos, GlaxoSmithKline, and Millennium (a Takeda company).
Dr. Sandborn also serves on the Speakers Bureau for AbbVie, and has received research grants from Janssen, Bristol-Myers Squibb, Genentech, Amgen, Pfizer, Receptos and GlaxoSmithKline.
Dr. Dubinsky has served as a consultant for Janssen, Pfizer, Bristol-Myers Squibb, UCB, Abbott, Shire, Prometheus, and Takeda, and has received a research grant from Janssen.
Dr. Rubin serves as a consultant for Prometheus Pharmaceuticals, AbbVie (Abbott Immunology), UCB Pharma, Centocor/Janssen, Elan Pharmaceuticals, Takeda-Millennium, Given Imaging, Bristol-Meyers Squibb, Ironwood, Lifecore Biomedical, LLC, Emmi, Telsar Pharmaceuticals, Vertex Pharmaceuticals, and Santarus.
Dr. Rubin has also received grants or research support from Warner Chilcott, Prometheus Pharmaceuticals, AbbVie (Abbott Immunology) (Registry), Shire, and Elan Pharmaceuticals (Registry).
Additionally, Dr. Rubin is co-founder of Cornerstones Health, Inc., a non-profit medical education entity.
Program planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
Cynthia M. Kunzer, CMP, has no affiliations with commercial interests to disclose.
AGA Planning Committee
AGA Staff and all other individuals with the planning and delivering the content disclosed no relevant financial relationships.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information and comparison with recommendations of other authorities.
This is a program of the AGA in collaboration with RMEI, LLC. RMEI gratefully acknowledges an educational grant from Takeda Pharmaceuticals North America, Inc. in support of this CME activity.
There is no fee for this educational activity.
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5 and above
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above